Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Century Therapeutics, Inc. (IPSC)  
$0.00 0.00 (0.00%) as of 4:30 Tue 11/30


Download
   
Exchange: N/A
Security Type: N/A
Shares Out: 54,820,000
Market Cap: N/A
Last Volume: 0 Avg Vol: 0
52 Week Range: $ - $
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

                 
 
Company Profile   Century Therapeutics is a biotechnology company developing transformative allogeneic cell therapies to create products for the treatment of both solid tumor and hematological malignancies with unmet medical need. Co.'s primary product candidate, CNTY-101, is an allogeneic, chimeric antigen receptors (CAR)-induce pluripotent stem cell-derived (iPSC-derived) natural killer (iNK) cell therapy that has been engineered to express CD19 CAR, soluble IL-15, an epidermal growth factor receptor safety switch, and also contains gene edits needed to incorporate Allo-Evasion™ technology. CNTY-103 is Co.'s main product candidate targeting a solid tumor.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 5,000 5,000
Total Buy Value $0 $0 $7,657 $7,657
Total People Bought 0 0 1 1
Total Buy Transactions 0 0 1 1
Total Shares Sold 37,328 81,639 91,703 171,892
Total Sell Value $20,875 $54,190 $78,465 $436,005
Total People Sold 4 4 4 4
Total Sell Transactions 7 14 22 35
End Date 2025-03-16 2024-12-13 2024-06-14 2023-06-15

   
Records found: 93
  Page 1 of 4  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Russotti Gregory See Remarks   •       –      –    2025-06-09 4 S $0.62 $327 D/D (526) 392,047     -
   Pfeiffenberger Brent President and CEO   •       •      –    2025-06-09 4 S $0.62 $295 D/D (475) 1,681,783     -
   Farid Adrienne Chief Operations Officer   •       –      –    2025-06-09 4 S $0.62 $343 D/D (552) 250,141     -
   Carr Douglas SVP Finance & Operations   •       –      –    2025-06-09 4 S $0.62 $3,050 D/D (4,904) 405,982     -
   Pfeiffenberger Brent President and CEO   •       •      –    2025-05-16 4 S $0.55 $16,135 D/D (29,552) 1,682,258     -
   Farid Adrienne Chief Operations Officer   •       –      –    2025-05-05 4 S $0.55 $563 D/D (1,024) 250,693     -
   Carr Douglas SVP Finance & Operations   •       –      –    2025-05-05 4 S $0.55 $162 D/D (295) 410,886     -
   Cowan Chad Chief Scientific Officer   •       –      –    2025-03-11 4 A $0.00 $0 D/D 19,500 230,306     -
   Conn Morgan Chief Finanical Officer   •       –      –    2025-03-11 4 A $0.00 $0 D/D 19,500 79,648     -
   Pfeiffenberger Brent President and CEO   •       •      –    2025-03-11 4 A $0.00 $0 D/D 521,500 1,711,810     -
   Russotti Gregory See Remarks   •       –      –    2025-03-11 4 A $0.00 $0 D/D 120,000 392,573     -
   Carr Douglas SVP Finance & Operations   •       –      –    2025-03-11 4 A $0.00 $0 D/D 95,625 411,181     -
   Farid Adrienne Chief Operations Officer   •       –      –    2025-03-11 4 A $0.00 $0 D/D 120,000 251,717     -
   Pfeiffenberger Brent President and CEO   •       •      –    2025-03-10 4 S $0.62 $1,375 D/D (2,235) 1,190,310     -
   Russotti Gregory See Remarks   •       –      –    2025-03-10 4 S $0.62 $1,451 D/D (2,360) 272,573     -
   Carr Douglas SVP Finance & Operations   •       –      –    2025-03-10 4 S $0.62 $763 D/D (1,240) 315,556     -
   Farid Adrienne Chief Operations Officer   •       –      –    2025-03-10 4 S $0.62 $1,451 D/D (2,359) 131,717     -
   Pfeiffenberger Brent President and CEO   •       •      –    2025-02-18 4 S $0.78 $27,179 D/D (34,712) 1,192,545     -
   Farid Adrienne Chief Operations Officer   •       –      –    2025-02-03 4 S $0.78 $822 D/D (1,054) 134,076     -
   Carr Douglas SVP Finance & Operations   •       –      –    2025-02-03 4 S $0.78 $274 D/D (351) 316,796     -
   Pfeiffenberger Brent President and CEO   •       •      –    2024-12-04 4 D $1.44 $350,564 D/D (243,447) 1,227,257     -
   Farid Adrienne Chief Operations Officer   •       –      –    2024-11-04 4 S $1.23 $1,267 D/D (1,033) 135,130     -
   Carr Douglas SVP Finance & Operations   •       –      –    2024-11-04 4 S $1.23 $347 D/D (283) 317,147     -
   Carr Douglas SVP Finance & Operations   •       –      –    2024-11-01 4 D $1.26 $20,930 D/D (16,611) 317,430     -
   Conn Morgan Chief Finanical Officer   •       –      –    2024-10-14 4 A $0.00 $0 D/D 60,148 60,148     -
  93 Records found
  1  2  3  4   
  Page 1 of 4
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2025 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us